John B. Moriarty, EVP & General Counsel at ALEXION PHARMACEUTICALS INC (ALXN), sold 4,602 shares at $145.27 ($646K) on 2016-02-05, disclosed to the SEC on 2016-02-08.
Seasonal sale ($646k) by EVP & General Counsel — this insider has traded ALXN in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $141.75 | 433 | $61K | 9.5% |
| 2 | $142.18 | 436 | $62K | 9.6% |
| 3 | $143.44 | 200 | $29K | 4.4% |
| 4 | $144.39 | 400 | $58K | 8.9% |
| 5 | $145.27 | 500 | $73K | 11.2% |
| 6 | $138.02 | 137 |
| $19K |
| 2.9% |
| 7 | $138.02 | 2,418 | $334K | 51.7% |
| 8 | $140.21 | 78 | $11K | 1.7% |
| Total | $140.38 avg | 4,602 | $646K | 100% |
| Filing → |
| ALXN | SELL | 2018-02-08 | $639K | — | Filing → |
| ALXN | SELL | 2018-02-07 | $296K | — | Filing → |
| ALXN | SELL | 2017-03-01 | $438K | — | Filing → |